February 18, 2025

George Vradenburg and the Global Impact of Alzheimer's (part 1)

George Vradenburg and the Global Impact of Alzheimer's (part 1)

About This Episode

Alzheimer’s is not just an aging issue, but a lifelong brain health challenge that has major global, economic, and societal implications. George Vradenburg, Chairman and Founder of UsAgainstAlzheimer’s, who has incubated satellite organizations globally to address these issues, debriefs BrainStorm host Meryl Comer on the recent launch of “Brain House” at the Davos World Economic Forum.  Together they explore the potential role of AI in enhancing brain capacity, the fragile state of Alzheimer's research funding, and the business case for diverse representation in clinical trials. You don’t want to miss this leadership episode!

 

BrainStorm Feed

100

2025 Year in Review and Predictions for 2026 with George Vradenburg

George Vradenburg, Chairman and Founder of UsAgainstAlzheimer's, sits down with host Meryl Comer for a comprehensive look at the state of Alzheimer's research, advocacy, and care in 2025.
LISTEN NOW
99

The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform (part 2)

In part 2 John Dwyer, CEO of the Global Alzheimer's Platform (GAP), and BrainStorm host Meryl Comer discuss transforming Alzheimer's research and clinical trials.
LISTEN NOW
98

The Future of Alzheimer's Trials: Bringing Cutting-Edge Research to Every Community - John Dwyer, CEO of The Global Alzheimer's Platform

John Dwyer, CEO of the Global Alzheimer's Platform (GAP), highlights GAP's innovations in improving the participant experience through streamlining visits, personalized feedback, and bringing mobile trials directly to small communities.
LISTEN NOW